Open Access
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation
Valentina Di Cristo
1
,
Fulvio Adorni
2
,
Renato Maserati
3
,
Marco Annovazzi Lodi
3
,
Giuseppe Bruno
4
,
Paolo Maggi
4
,
Anna Volpe
4
,
Paola Vitiello
5
,
Clara Abeli
5
,
Stefano Bonora
6
,
Micol Ferrara
6
,
Maria Vittoria Cossu
7
,
Maria Letizia Oreni
1
,
Elisa Colella
1
,
1
2
ITB‐CNR, Segrate, MI, Italy;
|
5
Infectious Diseases Unit, ASST Valle Olona, Ospedale di Circolo, Busto Arsizio, VA, Italy;
|
7
First Infectious Diseases Unit, ASST Fatebenefratelli‐Sacco, Milan, Italy
|
Тип публикации: Journal Article
Дата публикации: 2020-01-02
scimago Q2
wos Q3
БС3
SJR: 0.693
CiteScore: 2.6
Impact factor: 1.8
ISSN: 25787489, 25787470
PubMed ID:
32129161
Infectious Diseases
Pharmacology (medical)
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
|
|
|
Diagnostics
1 публикация, 14.29%
|
|
|
Frontiers in Pharmacology
1 публикация, 14.29%
|
|
|
eLife
1 публикация, 14.29%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 14.29%
|
|
|
Expert Opinion on Drug Safety
1 публикация, 14.29%
|
|
|
Brazilian Journal of Infectious Diseases
1 публикация, 14.29%
|
|
|
1
|
Издатели
|
1
2
|
|
|
Elsevier
2 публикации, 28.57%
|
|
|
MDPI
1 публикация, 14.29%
|
|
|
Frontiers Media S.A.
1 публикация, 14.29%
|
|
|
eLife Sciences Publications
1 публикация, 14.29%
|
|
|
Taylor & Francis
1 публикация, 14.29%
|
|
|
Cold Spring Harbor Laboratory
1 публикация, 14.29%
|
|
|
1
2
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
7
Всего цитирований:
7
Цитирований c 2024:
1
(14.29%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Di Cristo V. et al. 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation // HIV Research and Clinical Practice. 2020. Vol. 21. No. 1. pp. 34-43.
ГОСТ со всеми авторами (до 50)
Скопировать
Di Cristo V., Adorni F., Maserati R., Annovazzi Lodi M., Bruno G., Maggi P., Volpe A., Vitiello P., Abeli C., Bonora S., Ferrara M., Cossu M. V., Oreni M. L., Colella E., Rusconi S. 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation // HIV Research and Clinical Practice. 2020. Vol. 21. No. 1. pp. 34-43.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1080/25787489.2020.1734752
UR - https://doi.org/10.1080/25787489.2020.1734752
TI - 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation
T2 - HIV Research and Clinical Practice
AU - Di Cristo, Valentina
AU - Adorni, Fulvio
AU - Maserati, Renato
AU - Annovazzi Lodi, Marco
AU - Bruno, Giuseppe
AU - Maggi, Paolo
AU - Volpe, Anna
AU - Vitiello, Paola
AU - Abeli, Clara
AU - Bonora, Stefano
AU - Ferrara, Micol
AU - Cossu, Maria Vittoria
AU - Oreni, Maria Letizia
AU - Colella, Elisa
AU - Rusconi, Stefano
PY - 2020
DA - 2020/01/02
PB - Taylor & Francis
SP - 34-43
IS - 1
VL - 21
PMID - 32129161
SN - 2578-7489
SN - 2578-7470
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Di Cristo,
author = {Valentina Di Cristo and Fulvio Adorni and Renato Maserati and Marco Annovazzi Lodi and Giuseppe Bruno and Paolo Maggi and Anna Volpe and Paola Vitiello and Clara Abeli and Stefano Bonora and Micol Ferrara and Maria Vittoria Cossu and Maria Letizia Oreni and Elisa Colella and Stefano Rusconi},
title = {96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation},
journal = {HIV Research and Clinical Practice},
year = {2020},
volume = {21},
publisher = {Taylor & Francis},
month = {jan},
url = {https://doi.org/10.1080/25787489.2020.1734752},
number = {1},
pages = {34--43},
doi = {10.1080/25787489.2020.1734752}
}
Цитировать
MLA
Скопировать
Di Cristo, Valentina, et al. “96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation.” HIV Research and Clinical Practice, vol. 21, no. 1, Jan. 2020, pp. 34-43. https://doi.org/10.1080/25787489.2020.1734752.